Non-Small Cell Adenocarcinoma — Research

Non-Small Cell Adenocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	33	`("Non-Small Cell Adenocarcinoma"[tiab] OR "Nonsmall Cell Adenocarcinoma"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	14	`("Non-Small Cell Adenocarcinoma"[tiab] OR "Nonsmall Cell Adenocarcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	2	`("Non-Small Cell Adenocarcinoma"[tiab] OR "Nonsmall Cell Adenocarcinoma"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (98)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 98 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
· Ann Oncol · 2017 · PMID 28950338 · validated civic_curation pubmed
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.
· Lung Cancer · 2022 · PMID 35245845 · validated civic_curation pubmed
A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case Report.
· Onco Targets Ther · 2021 · PMID 34163176 · validated civic_curation pubmed
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.